Welcome to our dedicated page for Ati Physical Therapy news (Ticker: ATIP), a resource for investors and traders seeking the latest updates and insights on Ati Physical Therapy stock.
About ATI Physical Therapy Inc. (ATIP)
ATI Physical Therapy Inc. (NYSE: ATIP) is a leading provider of outpatient musculoskeletal (MSK) rehabilitation services in the United States. Headquartered in Downers Grove, Illinois, ATI operates over 850 clinics across 24 states, making it one of the largest single-branded platforms in the physical therapy industry. Established in 1996, ATI has built a reputation for delivering high-quality, evidence-based care tailored to prevent and treat MSK disorders, including sports injuries, post-operative rehabilitation, and chronic pain management.
Comprehensive Rehabilitation Services
ATI offers a wide range of rehabilitation services, including physical therapy, aquatic therapy, hand therapy, sports medicine, industrial health services, and women's health programs. The company's patient-centered approach emphasizes hands-on, one-on-one care designed to improve patient outcomes. Through its proprietary Patient Outcomes Registry™, ATI tracks over 10 million patient-reported outcomes from more than 3 million unique patient cases, enabling data-driven treatment strategies that deliver predictable and impactful results.
Innovative Care Delivery
ATI leverages technology and standardized clinical guidelines to ensure consistency and quality across its network. Its virtual care platform, CONNECT™, expands access to physical therapy services, allowing patients to receive treatment remotely. Additionally, ATI's focus on value-based care models aligns with broader healthcare trends aimed at improving outcomes while reducing costs.
Commitment to Clinical Excellence
ATI's dedication to clinical excellence is reflected in its recognition by the Center for Medicare and Medicaid Services (CMS), which has awarded the company an "Exceptional" Merit-Based Incentive Payment System (MIPS) rating for five consecutive years. This distinction underscores ATI's commitment to delivering high-quality care that reduces unnecessary medical interventions, such as imaging, opioids, and surgery.
Industry Leadership and Research
In addition to its clinical services, ATI is advancing the field of musculoskeletal care through its Institute for Musculoskeletal Advancement (iMSKA). Founded to engage in scientific research and professional development, iMSKA focuses on improving diagnostic and treatment methodologies for MSK conditions. This initiative highlights ATI's role as a thought leader in the rehabilitation industry.
Challenges and Market Position
Operating in a competitive landscape, ATI faces challenges such as labor shortages and reimbursement pressures. However, its robust operational strategies, focus on clinician retention, and emphasis on patient outcomes position it as a resilient player in the outpatient rehabilitation market. By continuously investing in its workforce and clinical innovation, ATI aims to meet growing demand and maintain its leadership in the sector.
Conclusion
ATI Physical Therapy Inc. exemplifies a commitment to enhancing the quality of life for its patients through comprehensive, evidence-based rehabilitation services. Its scale, technological integration, and focus on clinical excellence make it a pivotal player in the U.S. healthcare landscape, addressing the critical need for accessible and effective MSK care.
ATI Physical Therapy (ATIP) and Tufts University School of Medicine announced a groundbreaking collaboration to expand access to physical therapy education. The initiative responds to a projected 27% increase in demand for physical therapy services by 2030. Key features include:
- Scholarships for up to 45 ATI employees per academic year in TUSM's Doctor of Physical Therapy (DPT) programs
- Sponsorship for 20 employees in TUSM-DPT's 12-week ADEPT program
- Increased access to clinical rotations at ATI's 850+ outpatient clinics
- Development of residency and fellowship training programs
- Joint research initiatives between TUSM and ATI
The collaboration aims to create accessible pathways for aspiring physical therapists, particularly targeting first-generation college students and those from lower-income households, while establishing a sustainable pipeline of skilled professionals.
ATI Physical Therapy (OTCMKTS: ATIP) has announced the termination of its previously announced tender offer to purchase up to 1,650,000 shares of its Class A common stock at $2.85 per share. The termination occurred because the Minimum Condition, which required 1,565,000 shares to be validly tendered, was not met.
As a result of the termination, no shares will be purchased and no consideration will be paid for any tendered shares. The tender offer was originally announced on December 17, 2024, and stockholders seeking additional information can contact Innisfree M&A Incorporated.
ATI Physical Therapy (ATIP) has announced a tender offer to purchase up to 1,650,000 shares of its Class A common stock at $2.85 per share, representing approximately 37.4% of outstanding shares. The offer price represents a 290% premium over the December 16, 2024 closing price of $0.73. The tender offer will be funded through new notes under the company's amended second lien PIK note purchase agreement.
The offer requires a minimum tender of 1,565,000 shares and will expire on January 15, 2025. Stockholders can tender all or part of their shares and will receive payment in cash, subject to proration if the offer is oversubscribed. The Board of Directors has unanimously recommended stockholders accept the offer.
ATI Physical Therapy (NYSE: ATIP) announced that its Class A common stock will be delisted from the New York Stock Exchange after market close on December 3, 2024, due to failing to maintain the required $15 million average global market capitalization over 30 consecutive trading days. The company's stock will transition to trading on the OTC Pink® Market.
ATI is currently in discussions for interim financing to provide liquidity opportunities for stockholders. The company states this transition won't affect its business operations, partner relationships, employees, or SEC reporting obligations. Management expressed confidence in their strategic plan and ongoing investments in people and patient experiences.
ATI Physical Therapy (ATIP) has achieved an 'Exceptional' rating from the Center for Medicare and Medicaid Services' (CMS) Merit-Based Incentive Payment System (MIPS) for the fifth consecutive year since the program's inception in 2019. The company leveraged its proprietary electronic medical record and Patient Outcomes Registry™, which contains over 10 million patient reported outcomes across 4 million patient episodes. This recognition makes providers eligible for CMS reimbursement rate bonuses, helping offset continuing rate reductions. ATI, the largest single-branded outpatient physical therapy provider in the U.S., operates 900 locations across 24 states, offering comprehensive physical therapy services including virtual and workplace safety solutions.
ATI Physical Therapy (NYSE: ATIP) reported Q3 2024 financial results with net revenue of $190.0 million, up 7.1% from Q3 2023. Net patient revenue increased 7.7% to $174.7 million. The company reported a net loss of $32.9 million and Adjusted EBITDA of $12.1 million, up 28.8% year-over-year. Visits per Day increased 6.1% to 24,860. For Q4 2024, ATI projects revenue between $182-192 million and Adjusted EBITDA of $9-14 million. The company noted its liquidity position requires additional capital to fund operations and meet near-term needs.
ATI Physical Therapy, Inc. (NYSE: ATIP), a leading outpatient physical therapy provider in the United States, has announced that it will release its third quarter 2024 financial results on Monday, November 4, 2024, after the market closes. The company will host a conference call to review the results at 5 p.m. ET on the same day.
Interested parties can access the live audio webcast of the conference call through the ATI Physical Therapy, Inc. Q3 2024 Earnings Conference Call link on the company's Investor Relations website at https://investors.atipt.com. Participants are advised to join at least 15 minutes early to register and download any necessary audio software. A replay of the call will be available for on-demand listening shortly after the completion of the call and will remain accessible for approximately 90 days.
ATI Physical Therapy (NYSE: ATIP) reported strong growth in Q2 2024, with revenue increasing 9.2% to $188.1 million. Key highlights include:
- Patient visits up 6.4% to 24,921 per day
- Rate per Visit increased 3.4% to $108.32
- Adjusted EBITDA grew 77.5% to $16.6 million
- Net loss narrowed to $2.6 million from $21.7 million in Q2 2023
The company received an exceptional MIPS rating for the 5th consecutive year. For Q3 2024, ATI guides revenue between $180-$190 million and Adjusted EBITDA of $9-$14 million.
ATI Physical Therapy (NYSE: ATIP), a leading outpatient physical therapy provider in the United States, has announced that it will release its second quarter 2024 financial results on Monday, August 5, 2024, after the market closes. The company will host a conference call to review the results at 5 p.m. ET on the same day.
Investors and interested parties can access the live audio webcast of the conference call through the ATI Physical Therapy, Inc. Q2 2024 Earnings Conference Call link on the company's Investor Relations website at https://investors.atipt.com. Participants are advised to join at least 15 minutes early to register and download any necessary audio software. A replay of the call will be available for on-demand listening shortly after the call's completion and will remain accessible for approximately 90 days.
ATI Physical Therapy (NYSE: ATIP) has announced a settlement notice, which is now available on the investor relations section of its website. This update aims to inform stakeholders about the details of the settlement. ATI Physical Therapy is a prominent outpatient physical therapy provider in the US.